EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Transition-Metal-Oxide-Based Nanozymes for Antitumor Applications

Huilin Sun, Yang Bai, Donghui Zhao, Jianhao Wang, Lin Qiu iD

Materials · 13.06.2024 · 17 (12) · 2896

DOI: 10.3390/ma17122896 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Materials, online erschienen am 13.06.2024. Verfasst von Huilin Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Changzhou University, Changzhou 213164, China. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Changzhou Leading Innovative Talents Introduction and Cultivation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transition metal oxide (TMO)-based nanozymes have appeared as hopeful tools for antitumor applications due to their unique catalytic properties and ability to modulate the tumor microenvironment (TME). The purpose of this review is to provide an overview of the latest progress made in the field of TMO-based nanozymes, focusing on their enzymatic activities and participating metal ions. These nanozymes exhibit catalase (CAT)-, peroxidase (POD)-, superoxide dismutase (SOD)-, oxidase (OXD)-, and glutathione oxidase (GSH-OXD)-like activities, enabling them to regulate reactive oxygen species (ROS) levels and glutathione (GSH) concentrations within the TME. Widely studied transition metals in TMO-based nanozymes include Fe, Mn, Cu, Ce, and the hybrid multimetallic oxides, which are also summarized. The review highlights several innovative nanozyme designs and their multifunctional capabilities. Despite the significant progress in TMO-based nanozymes, challenges such as long-term biosafety, targeting precision, catalytic mechanisms, and theoretical supports remain to be addressed, and these are also discussed. This review contributes to the summary and understanding of the rapid development of TMO-based nanozymes, which holds great promise for advancing nanomedicine and improving cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

antitumorchemodynamic therapynanozymetransition metal oxide

Autor:innen und Institutionen

  • School of Pharmacy, Changzhou University, Changzhou 213164, China.

ORCID-Profile: Lin Qiu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Changzhou Leading Innovative Talents Introduction and Cultivation Project
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province

Zitieren

APA

Sun, H., Bai, Y., Zhao, D., Wang, J., & Qiu, L. (2024). Transition-Metal-Oxide-Based Nanozymes for Antitumor Applications. Materials, 17(12), 2896. https://doi.org/10.3390/ma17122896

Vancouver

Sun H, Bai Y, Zhao D, Wang J, Qiu L. Transition-Metal-Oxide-Based Nanozymes for Antitumor Applications. Materials. 2024;17(12):2896. doi:10.3390/ma17122896

BibTeX
@article{Sun2024,
  author = {Sun, Huilin and Bai, Yang and Zhao, Donghui and Wang, Jianhao and Qiu, Lin},
  title = {Transition-Metal-Oxide-Based Nanozymes for Antitumor Applications},
  journal = {Materials},
  year = {2024},
  volume = {17},
  number = {12},
  pages = {2896},
  doi = {10.3390/ma17122896}
}
Kostenlos starten →